NDRG2对唾液腺腺样囊性癌增殖、侵袭的影响

doi:10.19438/j.cjoms.2019.02.003

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (2): 112-116.doi: 10.19438/j.cjoms.2019.02.003

NDRG2对唾液腺腺样囊性癌增殖、侵袭的影响

任华健¹, 李家苏¹, 高红梅², 尹林¹

1.南京医科大学第一附属医院口腔科,江苏南京 210029;
2.济宁市人民医院口腔科,山东济宁 272000

收稿日期:2018-10-18 修回日期:2018-12-01 出版日期:2019-03-20 发布日期:2019-04-12
通讯作者: 尹林,E-mail：jssryyl@163.com
作者简介:任华健（1994-）,男,硕士研究生,E-mail：185919262@qq.com
基金资助:
江苏省教育厅自然科学基金（10KJB320005）; 江苏省卫生厅项目（H201306）

The effect of NDRG2 on proliferation and invasion of salivary adenoid cystic carcinoma

REN Hua-jian¹, LI Jia-su¹, GAO Hong-mei², YIN Lin¹

1.Department of Stomatology, Peoples Hospital of Jiangsu Province. Nanjing 210029, Jiangsu Province;
2. Department of Stomatology, Peoples Hospital of Jining. Jining 272000, Shandong Province, China

Received:2018-10-18 Revised:2018-12-01 Online:2019-03-20 Published:2019-04-12

摘要/Abstract

摘要： 目的:探讨NDRG2基因在唾液腺腺样囊性癌组织中的表达及其对SACC-LM细胞增殖、侵袭的影响。方法:采用蛋白质免疫印迹法（Western blot）和实时荧光定量PCR（qRT-PCR）分析唾液腺腺样囊性癌组织及癌旁组织样本中NDRG2的表达,采用RNA干扰技术降低腺样囊性癌细胞SACC-LM中NDRG2基因的表达,利用CCK-8实验及集落形成实验检测细胞增殖能力的变化,利用划痕实验及Transwell实验分别检测细胞迁移及侵袭能力的变化,利用Western 免疫印迹实验检测侵袭标志蛋白以及上皮-间充质转化（EMT）相关蛋白的表达。采用SPSS 17.0软件包进行数据处理。结果:NDRG2基因在唾液腺腺样囊性癌组织中的表达低于癌旁组织（P=0.017）。在降低NDRG2基因的表达后,SACC-LM细胞的增殖、迁移及侵袭能力显著增强（P<0.05）,侵袭标志蛋白MMP2表达量显著升高（P=0.0004）,上皮标志物E-Caherin表达量显著降低（P=0.0229）,间充质标志物N-Cadherin表达量显著升高（P=0.0009）。结论:NDRG2基因在腺样囊性癌中低表达,降低NDRG2的表达可增强SACC-LM的增殖、迁移及侵袭能力。

关键词: NDRG2, 腺样囊性癌, 增殖, 侵袭

Abstract: PURPOSE: To investigate the expression of NDRG2 gene and its role in the progress of salivary adenoid cystic carcinoma (SACC). METHODS: Western blot assay was used to analyze the expression level of protein of SACC. The mRNA level was analyzed by qRT-PCR assay. The expression level of NDRG2 in SACC-LM was downregulated by small interfering RNA. The proliferation of SACC-LM was detected by CCK-8 assay and colony formation assay. Wound healing assay and Transwell invasion assay were performed to observe the abilities of migration and invasion, respectively. The expression of invasion markers and EMT-related proteins was examined by Western blot. SPSS 17.0 software package was used for statistical analysis. RESULTS: NDRG2 expression was decreased in SACC tissues (P=0.017). Down-regulation of NDRG2 promoted proliferation,migration and invasion of SACC-LM (P<0.05). The expression of MMP2 (P=0.0004) was up-regulated. The epithelial marker E-Cadherin was down-regulated (P=0.0229) while the mesenchymal marker N-Cadherin was increased (P=0.0009). CONCLUSIONS: NDRG2 is decreased in SACC and Si-NDRG2 could enhance proliferation,migration and invasion of salivary adenoid cystic carcinoma cell line SACC-LM.

Key words: NDRG2, Salivary adenoid cystic carcinoma, Proliferation, Invasion

中图分类号:

R739.8

任华健, 李家苏, 高红梅, 尹林. NDRG2对唾液腺腺样囊性癌增殖、侵袭的影响[J]. 中国口腔颌面外科杂志, 2019, 17(2): 112-116.

REN Hua-jian, LI Jia-su, GAO Hong-mei, YIN Lin. The effect of NDRG2 on proliferation and invasion of salivary adenoid cystic carcinoma[J]. China J Oral Maxillofac Surg, 2019, 17(2): 112-116.

参考文献

[1] Mao W, Sun Y, Zhang H, et al.A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway[J]. Lasers Med Sci, 2016, 31(8): 1697-1705.
[2] Tang Y, Liang X, Zheng M, et al.Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma[J]. Oral Oncol, 2010, 46(4): 311-316.
[3] Yao X, Wang Y, Duan Y, et al.IGFBP2 promotes salivary adenoid cystic carcinoma metastasis by activating the NF-kappaB/ZEB1 signaling pathway[J]. Cancer Lett, 2018, 432: 38-46.
[4] Jang S, Patel PN, Kimple RJ, et al.Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the head and neck[J]. Anticancer Res, 2017, 37(6): 3045-3052.
[5] Dodd RL, Slevin NJ.Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies[J]. Oral Oncol, 2006, 42(8): 759-769.
[6] Wu HM, Ren GX, Wang LZ, et al.Expression of podoplanin in salivary gland adenoid cystic carcinoma and its association with distant metastasis and clinical outcomes[J]. Mol Med Rep, 2012, 6(2): 271-274.
[7] von Karstedt S. NDRG2 programs tumor-associated macrophages for tumor support[J]. Cell Death Dis, 2018, 9(3): 294-301.
[8] Shen L, Qu X, Li H, et al.NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis[J]. Oncogene, 2018, 37(13): 1759-1774.
[9] Yamamura A, Miura K, Karasawa H, et al.NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers[J]. Biochem Biophys Res Commun, 2017, 484(1): 138-143.
[10] Jin Z, Gu C, Tian F, et al.NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-beta1/Smad3 pathway[J]. Cell Tissue Res, 2017, 369(3): 603-610.
[11] Zheng J, Li Y, Yang J, et al. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression [J]. BMC Cancer, 2011, 11: 251: 1-9.
[12] Xu X, Li J, Sun X, et al.Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression[J]. Oncotarget, 2015, 6(28): 26161-26176.
[13] Lee DG, Lee SH, Kim JS, et al.Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression[J]. J Hepatol, 2015, 63(6): 1429-1439.
[14] Tamura T, Ichikawa T, Nakahata S, et al.Loss of NDRG2 expression confers oral squamous cell carcinoma with enhanced metastatic potential[J]. Cancer Res, 2017, 77(9): 2363-2674.
[15] Golestan A, Ghaderi A, Mojtahedi Z, et al.Effects of NDRG2 overexpression on metastatic behaviors of HCT116 colorectal cancer cell line[J]. Adv Pharm Bull, 2017, 7(4): 661-664.
[16] Bao Z, Xu X, Liu Y, et al.CBX7 negatively regulates migration and invasion in glioma via Wnt/beta-catenin pathway inactivation[J]. Oncotarget, 2017, 8(24): 39048-39063.
[17] Kim MJ, Lim J, Yang Y, et al.N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling[J]. Cancer Lett, 2014, 354(1): 33-42.

NDRG2对唾液腺腺样囊性癌增殖、侵袭的影响

The effect of NDRG2 on proliferation and invasion of salivary adenoid cystic carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈华, 李婧, 罗梅. 红景天甙通过NRF2/KEAP1通路对口腔鳞癌细胞生长的影响[J]. 中国口腔颌面外科杂志, 2024, 22(5): 424-429.
[2]	惠琪, 高万鹏, 李欢, 赵琦, 王珺, 魏建华, 杨新杰, 杨子桧. 唾液腺腺样囊性癌微环境中肿瘤相关巨噬细胞外泌体差异表达miRNAs的筛选及验证[J]. 中国口腔颌面外科杂志, 2024, 22(3): 209-215.
[3]	李华盛, 周迪, 韩楠男, 严明, 阮敏. 石蒜碱通过降解SCAP蛋白抑制口腔鳞癌细胞增殖与侵袭的实验研究[J]. 中国口腔颌面外科杂志, 2024, 22(1): 29-35.
[4]	林惠, 高云飞, 刘晶, 马旭辉. 槐角提取物对颌骨骨髓间充质干细胞成骨向分化的影响[J]. 中国口腔颌面外科杂志, 2024, 22(1): 73-77.
[5]	刘恒, 李永頔, 尹鑫海, 段晓峰. 铁蛋白重链1在头颈鳞癌中的表达及对口腔鳞癌增殖、迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2023, 21(6): 529-537.
[6]	程煜天, 徐乐, 马利, 吴海威, 陈占伟, 邹虎威, 张天奇, 刘桂军, 刘振兴, 尹长伟, 李文刚, 张世周, 黄圣运, 张东升. 头颈部腺样囊性癌预后分析：单中心经验[J]. 中国口腔颌面外科杂志, 2023, 21(5): 467-471.
[7]	许贵松, 杨功鑫, 游元和, 田卓炜, 肖孟, 杜仲, 王延安. 20例面部先天性浸润性脂肪增殖症的临床及影像学分析[J]. 中国口腔颌面外科杂志, 2023, 21(5): 472-478.
[8]	慕家宁, 袁文清, 陆洲, 赵阳, 王奇民, 童磊, 陈正岗. Cdc42在舌鳞状细胞癌中的表达及其对细胞增殖、迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2023, 21(3): 209-217.
[9]	胡永, 王琼, 赵大勇, 叶金海. 下颌下腺腺样囊性癌高级别转化1例报告[J]. 中国口腔颌面外科杂志, 2023, 21(2): 206-208.
[10]	瞿楚翔, 孙树洋, 张志愿. 从遗传异质性认识口腔鳞癌的侵袭过程[J]. 中国口腔颌面外科杂志, 2022, 20(2): 193-197.
[11]	何优雅, 张誉, 戴振霖, 林承重, 曹巍, 季彤. 长链非编码RNA CASC15在成釉细胞瘤中的差异表达及生物信息学分析[J]. 中国口腔颌面外科杂志, 2021, 19(5): 411-416.
[12]	赵婷婷, 冯艳青, 何倩婷, 莫云龙, 董恩恩, 王安训. ATIP1和ATIP3a对口腔恶性肿瘤细胞增殖和凋亡的影响[J]. 中国口腔颌面外科杂志, 2021, 19(5): 417-423.
[13]	水文军, 高金星, 任蕾. 基质金属蛋白酶9抑制剂对人舌鳞癌SCC-25细胞侵袭、迁移能力的影响及机制探讨[J]. 中国口腔颌面外科杂志, 2021, 19(5): 424-428.
[14]	郭铭, 陈羽菱, 吴利, 张璧茹, 沈月洪, 杨宏宇. SREBP2对口腔鳞癌细胞增殖和迁移的影响及其调控机制[J]. 中国口腔颌面外科杂志, 2021, 19(4): 295-301.
[15]	张莹, 吴利, 陈羽菱, 林云涛, 沈月洪, 杨宏宇. POLD1对口腔鳞癌细胞增殖、侵袭的影响及调控机制[J]. 中国口腔颌面外科杂志, 2021, 19(4): 302-308.